CTNM vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

CTNM

52.3
AI Score
VS
JBIO Wins

JBIO

64.9
AI Score

Investment Advisor Scores

CTNM

52score
Recommendation
HOLD

JBIO

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CTNM JBIO Winner
Net Income -42.26M -96.13M CTNM
Operating Income -50.89M -102.36M CTNM
ROE -21.3% -21.9% CTNM
ROA -19.9% -20.4% CTNM
Total Assets 212.85M 472.11M JBIO
Cash 21.94M 107.25M JBIO
Current Ratio 20.69 14.93 CTNM
Free Cash Flow -33.36M -67.93M CTNM

Relative Price Performance (Last 90 Days)

CTNM 1M: -37.7% · 3M: -41.9% JBIO 1M: -9.7% · 3M: -22.9%

Current Technical Phase

CTNM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.1%), weak momentum, RSI 33

RSI (14): 32.6 · Price: $8.35

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.5 · Price: $15.13

Fundamentals Snapshot

Metric CTNM JBIO
Market Cap — —
Forward P/E -4.3 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.73 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.